Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer.
暂无分享,去创建一个
J. Roboz | H. Gretz | J. Holland | T. Ohnuma | F. Wilhelm | M. Maniar | L. Silverman | M. Sung | S. Cho | E. Wilck | D. Taft | S. Navada | C. Ren | D. Lehrer | V. Benisovich | Eugene Akahoho